AAAAAA

   
Results: 1-25 | 26-48
Results: 1-25/48
HEMATOLOGIC AND VIROLOGICAL EFFECTS OF LINEAGE-SPECIFIC AND NON-LINEAGE-SPECIFIC RECOMBINANT HUMAN AND RHESUS CYTOKINES IN A COHORT OF SIVMAC239-INFECTED MACAQUES
Authors: BUCUR SZ LACKEY DA ADAMS JW LEE ME VILLINGER F MAYNE A BRAY RA WINTON EF NOVEMBRE F STROBERT EA DEROSAYRO J DAILEY PJ ANSARI AA HILLYER CD
Citation: Sz. Bucur et al., HEMATOLOGIC AND VIROLOGICAL EFFECTS OF LINEAGE-SPECIFIC AND NON-LINEAGE-SPECIFIC RECOMBINANT HUMAN AND RHESUS CYTOKINES IN A COHORT OF SIVMAC239-INFECTED MACAQUES, AIDS research and human retroviruses, 14(8), 1998, pp. 651-660
PLATELET RECOVERY FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION CORRELATES WITH THE CONTENT OF CD34-CELLS IN THE MARROW GRAFT(, CD38)
Authors: WALLER EK WORFORD LJ LYNN M WINTON EF BRAY RA JONES W ROSENTHAL H MCCOLLUM J HOLLAND HK YEAGER AM
Citation: Ek. Waller et al., PLATELET RECOVERY FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION CORRELATES WITH THE CONTENT OF CD34-CELLS IN THE MARROW GRAFT(, CD38), Experimental hematology, 25(8), 1997, pp. 598-598
PRESENCE OF MINIMAL RESIDUAL DISEASE (MRD) IN ACUTE MYELOGENOUS LEUKEMIA (AML) PATIENTS PREALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) IS ASSOCIATED WITH A LOWER RELAPSE-FREE SURVIVAL (RFS)
Authors: HOLLAND HK BRAY RA OTOOLE K HOLDEN JT CONNAGHAN DG HEFFNER LT WALLER EK WINTON EF YEAGER AM
Citation: Hk. Holland et al., PRESENCE OF MINIMAL RESIDUAL DISEASE (MRD) IN ACUTE MYELOGENOUS LEUKEMIA (AML) PATIENTS PREALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) IS ASSOCIATED WITH A LOWER RELAPSE-FREE SURVIVAL (RFS), Experimental hematology, 25(8), 1997, pp. 621-621
ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH MATCHED UNRELATED DONORS FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES USING A PREPARATIVE REGIMENOF HIGH-DOSE CYCLOPHOSPHAMIDE AND FRACTIONATED TOTAL-BODY IRRADIATION
Authors: GELLER RB DEVINE SM OTOOLE K PERSONS L KELLER J MAUER D HOLLAND HK DIX SP PIOTTI M REDEI I CONNAGHAN G HEFFNER LT HILLYER CD WALLER EK WINTON EF WINGARD JR
Citation: Rb. Geller et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH MATCHED UNRELATED DONORS FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES USING A PREPARATIVE REGIMENOF HIGH-DOSE CYCLOPHOSPHAMIDE AND FRACTIONATED TOTAL-BODY IRRADIATION, Bone marrow transplantation, 20(3), 1997, pp. 219-225
ECTOPIC EXPRESSION OF P185 BCR-ABL IN HUMAN AML HL-60 CELLS BLOCKS MYELOID BUT ALLOWS ERYTHROID-DIFFERENTIATION AND GROWTH-INHIBITION DUE TO LOW-DOSE ARA-C OR ATRA
Authors: HUANG Y KIM CN HOLDEN J AMARANTEMENDES GP WINTON EF PERKINS CL GREEN DR BHALLA K
Citation: Y. Huang et al., ECTOPIC EXPRESSION OF P185 BCR-ABL IN HUMAN AML HL-60 CELLS BLOCKS MYELOID BUT ALLOWS ERYTHROID-DIFFERENTIATION AND GROWTH-INHIBITION DUE TO LOW-DOSE ARA-C OR ATRA, Blood, 90(10), 1997, pp. 3998-3998
THE NUMBER OF CD34- CELLS IN THE GRAFT PREDICTS THE KINETICS OF HEMATOPOIETIC RECONSTITUTION FOLLOWING AUTOLOGOUS OR ALLOGENEIC BONE-MARROWTRANSPLANTATION (BMT)(, CD38)
Authors: WALLER EK LYNN M WORFORD L WINTON EF REDEI I HEFFNER T HILLYER CD SMITH K BUCUR S LOPEZ R BRAY RA JONES W ROSENTHAL H MCCOLLUM J YEAGER AM
Citation: Ek. Waller et al., THE NUMBER OF CD34- CELLS IN THE GRAFT PREDICTS THE KINETICS OF HEMATOPOIETIC RECONSTITUTION FOLLOWING AUTOLOGOUS OR ALLOGENEIC BONE-MARROWTRANSPLANTATION (BMT)(, CD38), Blood, 90(10), 1997, pp. 1753-1753
7.5 GY IRRADIATION ATTENUATES THE GRAFT-VS-HOST DISEASE (GVHD) POTENTIAL OF ALLOGENEIC LYMPHOCYTES WHILE PRESERVING ANTILEUKEMIC ACTIVITY IN PRECLINICAL AND CLINICAL-STUDIES
Authors: WALLER EK REDEI I YEAGER AM WINTON EF HEFFNER T HILLYER CD CARTER R SMITH K HOLLAND HK CONNAGHAN G PHILLIPS C HOLDEN JT GUERRIERO A MURRAY T WORFORD L JURICKOVA I BOYER M
Citation: Ek. Waller et al., 7.5 GY IRRADIATION ATTENUATES THE GRAFT-VS-HOST DISEASE (GVHD) POTENTIAL OF ALLOGENEIC LYMPHOCYTES WHILE PRESERVING ANTILEUKEMIC ACTIVITY IN PRECLINICAL AND CLINICAL-STUDIES, Blood, 90(10), 1997, pp. 2437-2437
HIGH-DOSE CYCLOPHOSPHAMIDE, FRACTIONATED TOTAL-BODY IRRADIATION WITH INVOLVED FIELD IRRADIATION AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN MALIGNANT-LYMPHOMA
Authors: TIRONA MRBT GORDON DS CROCKER I ELEY JW YORK R HEFFNER LT WINTON EF VOGLER WR
Citation: Mrbt. Tirona et al., HIGH-DOSE CYCLOPHOSPHAMIDE, FRACTIONATED TOTAL-BODY IRRADIATION WITH INVOLVED FIELD IRRADIATION AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN MALIGNANT-LYMPHOMA, Leukemia & lymphoma, 20(3-4), 1996, pp. 249-257
MINIMAL TOXICITY AND MORTALITY IN HIGH-RISK BREAST-CANCER PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE, THIOTEPA, AND CARBOPLATIN PLUS AUTOLOGOUS MARROW STEM-CELL TRANSPLANTATION AND COMPREHENSIVE SUPPORTIVE CARE
Authors: HOLLAND HK DIX SP GELLER RB DEVINE SM HEFFNER LT CONNAGHAN DG HILLYER CD HUGHES LL MILLER RL MOORE MR WINTON EF WINGARD JR
Citation: Hk. Holland et al., MINIMAL TOXICITY AND MORTALITY IN HIGH-RISK BREAST-CANCER PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE, THIOTEPA, AND CARBOPLATIN PLUS AUTOLOGOUS MARROW STEM-CELL TRANSPLANTATION AND COMPREHENSIVE SUPPORTIVE CARE, Journal of clinical oncology, 14(4), 1996, pp. 1156-1164
LONG-TERM FOLLOW-UP OF EDELFOSINE PURGING FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ACUTE-LEUKEMIA
Authors: VOGLER WR BERDEL WE WINTON EF GORDON DS GELLER RB HEFFNER LT BROCHSTEIN JA BEVERIDGE RA DALTON WS MILLER KB LAZARUS HM
Citation: Wr. Vogler et al., LONG-TERM FOLLOW-UP OF EDELFOSINE PURGING FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ACUTE-LEUKEMIA, Experimental hematology, 24(9), 1996, pp. 615-615
PROFILE OF CELL-CYCLE IN HEMATOPOIETIC MALIGNANCY BY DNA RNA QUANTITATION USING 7AAD/PY/
Authors: TOBA K KISHI K KOIKE T WINTON EF TAKAHASHI H NAGAI K MARUYAMA S FURUKAWA T HASHIMOTO S MASUKO M UESUGI Y KUROHA T TSUKADA N SHIBATA A
Citation: K. Toba et al., PROFILE OF CELL-CYCLE IN HEMATOPOIETIC MALIGNANCY BY DNA RNA QUANTITATION USING 7AAD/PY/, Experimental hematology, 24(8), 1996, pp. 894-901
ASSOCIATION OF BUSULFAN AREA-UNDER-THE-CURVE WITH VENOOCCLUSIVE DISEASE FOLLOWING BMT
Authors: DIX SP WINGARD JR MULLINS RE JERKUNICA I DAVIDSON TG GILMORE CE YORK RC LIN LS DEVINE SM GELLER RB HEFFNER LT HILLYER CD HOLLAND HK WINTON EF SARAL R
Citation: Sp. Dix et al., ASSOCIATION OF BUSULFAN AREA-UNDER-THE-CURVE WITH VENOOCCLUSIVE DISEASE FOLLOWING BMT, Bone marrow transplantation, 17(2), 1996, pp. 225-230
VANCOMYCIN-RESISTANT AUREOBACTERIUM SPECIES CELLULITIS AND BACTEREMIAIN A PATIENT WITH ACUTE MYELOGENOUS LEUKEMIA
Authors: NOLTE FS ARNOLD KE SWEAT H WINTON EF FUNKE G
Citation: Fs. Nolte et al., VANCOMYCIN-RESISTANT AUREOBACTERIUM SPECIES CELLULITIS AND BACTEREMIAIN A PATIENT WITH ACUTE MYELOGENOUS LEUKEMIA, Journal of clinical microbiology, 34(8), 1996, pp. 1992-1994
STUDIES OF THE EFFECTS OF RECOMBINANT HUMAN (RH) AND RHESUS (RH) CYTOKINES ON HEMATOLOGIC AND VIROLOGICAL PARAMETERS IN A COHORT SIVMAC239 INFECTED MACAQUES
Authors: HILLYER CD LACKEY DA BUCUR SZ ADAMS JW LEE ME BUCCOLO LS TRAINOR LD VILLINGER F MAYNE A BRAY RA WINTON EF NOVEMBRE F ANSARI AA
Citation: Cd. Hillyer et al., STUDIES OF THE EFFECTS OF RECOMBINANT HUMAN (RH) AND RHESUS (RH) CYTOKINES ON HEMATOLOGIC AND VIROLOGICAL PARAMETERS IN A COHORT SIVMAC239 INFECTED MACAQUES, Blood, 88(10), 1996, pp. 1376-1376
RECOMBINANT HUMAN (RH) FLT3 LIGAND PLUS RHGM-CSF OR RHG-CSF CAUSES A MARKED CD34-MONKEYS( CELL MOBILIZATION TO BLOOD IN RHESUS)
Authors: WINTON EF BUCUR SZ BOND LD HEGWOOD AJ HILLYER CD HOLLAND NK WILLIAMS DE MCCLURE HM TROUTT AB LYMAN SD
Citation: Ef. Winton et al., RECOMBINANT HUMAN (RH) FLT3 LIGAND PLUS RHGM-CSF OR RHG-CSF CAUSES A MARKED CD34-MONKEYS( CELL MOBILIZATION TO BLOOD IN RHESUS), Blood, 88(10), 1996, pp. 2556-2556
REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION FOR BCR ABL FUSION INCHRONIC MYELOGENOUS LEUKEMIA/
Authors: WELLS SJ PHILLIPS CN WINTON EF FARHI DC
Citation: Sj. Wells et al., REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION FOR BCR ABL FUSION INCHRONIC MYELOGENOUS LEUKEMIA/, American journal of clinical pathology, 105(6), 1996, pp. 756-760
ANTIPROLIFERATIVE EFFECT OF HUMAN INTERLEUKIN-4 IN HUMAN CANCER CELL-LINES - STUDIES ON THE MECHANISM
Authors: TOPP MS PAPADIMITRIOU CA EITELBACH F OELMANN E KOEHLER B OBERBERG D VONMARSCHALL Z REUFI B STEIN H THIEL E WINTON EF BERDEL WE
Citation: Ms. Topp et al., ANTIPROLIFERATIVE EFFECT OF HUMAN INTERLEUKIN-4 IN HUMAN CANCER CELL-LINES - STUDIES ON THE MECHANISM, Leukemia & lymphoma, 19(3-4), 1995, pp. 319-328
TREATMENT OF CHRONIC NEUTROPENIA ASSOCIATED WITH LARGE GRANULAR LYMPHOCYTOSIS WITH CYCLOSPORINE-A AND FILGRASTIM
Authors: JAKUBOWSKI A WINTON EF GENCARELLI A GABRILOVE J
Citation: A. Jakubowski et al., TREATMENT OF CHRONIC NEUTROPENIA ASSOCIATED WITH LARGE GRANULAR LYMPHOCYTOSIS WITH CYCLOSPORINE-A AND FILGRASTIM, American journal of hematology, 50(4), 1995, pp. 288-291
PREDICTION OF A THRESHOLD AND OPTIMALLY EFFECTIVE THROMBOCYTOPOIETIC DOSE OF RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) IN NONHUMAN-PRIMATES BASED ON MURINE PHARMACOKINETIC DATA
Authors: WINTON EF THOMAS GR MARIAN ML BUCUR SZ MCCLURE HM EATON DL
Citation: Ef. Winton et al., PREDICTION OF A THRESHOLD AND OPTIMALLY EFFECTIVE THROMBOCYTOPOIETIC DOSE OF RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) IN NONHUMAN-PRIMATES BASED ON MURINE PHARMACOKINETIC DATA, Experimental hematology, 23(8), 1995, pp. 879-879
PHASE-I MULTICENTER TRIAL OF INTERLEUKIN-6 THERAPY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ADVANCED BREAST-CANCER
Authors: LAZARUS HM WINTON EF WILLIAMS SF GRINBLATT D CAMPION M COOPER BW GUNN H MANFREDA S ISAACS RE
Citation: Hm. Lazarus et al., PHASE-I MULTICENTER TRIAL OF INTERLEUKIN-6 THERAPY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ADVANCED BREAST-CANCER, Bone marrow transplantation, 15(6), 1995, pp. 935-942
CHEMOTHERAPY-INDUCED HEMOLYTIC-UREMIC SYNDROME - DESCRIPTION OF A POTENTIAL ANIMAL-MODEL
Authors: HILLYER CD DUNCAN A LEDFORD M BARRETT TJ KLUMPP SA ANDERSON DC MCCLURE HM WINTON EF
Citation: Cd. Hillyer et al., CHEMOTHERAPY-INDUCED HEMOLYTIC-UREMIC SYNDROME - DESCRIPTION OF A POTENTIAL ANIMAL-MODEL, Journal of medical primatology, 24(2), 1995, pp. 68-73
SIMULTANEOUS 3-COLOR ANALYSIS OF THE SURFACE PHENOTYPE AND DNA-RNA QUANTITATION USING 7-AMINO-ACTINOMYCIN-D AND PYRONIN-Y
Authors: TOBA K WINTON EF KOIKE T SHIBATA A
Citation: K. Toba et al., SIMULTANEOUS 3-COLOR ANALYSIS OF THE SURFACE PHENOTYPE AND DNA-RNA QUANTITATION USING 7-AMINO-ACTINOMYCIN-D AND PYRONIN-Y, Journal of immunological methods, 182(2), 1995, pp. 193-207
TOTAL CD34-GEMM ARE NOT GOOD PREDICTORS OF TIME TO NEUTROPHIL ENGRAFTMENT FOLLOWING MATCHED UNRELATED DONOR (MUD) TRANSPLANTATION( CELL CONTENT AND CFU)
Authors: HOLLAND HK GELLER RB REDEI S BRAY R WINTON EF CONNAGHAN DG OTOOLE K PERSON L DEVINE SM WINGARD JR
Citation: Hk. Holland et al., TOTAL CD34-GEMM ARE NOT GOOD PREDICTORS OF TIME TO NEUTROPHIL ENGRAFTMENT FOLLOWING MATCHED UNRELATED DONOR (MUD) TRANSPLANTATION( CELL CONTENT AND CFU), Blood, 86(10), 1995, pp. 467-467
PHASE-I TRIAL OF BUSULFAN (BU), CYCLOPHOSPHAMIDE (CY), AND DIAZIQUONE(AZQ) FOLLOWING AUTOLOGOUS (AU) OR ALLOGENEIC (AL) BONE-MARROW TRANSPLANTATION (BMT)
Authors: DEVINE SM DIX SP GELLER RB HOLLAND HK COLBAUGH J CONNAGHAN DG FLEMING WH HILLYER CD MULLINS R WALLER EK WINTON EF WINGARD JR
Citation: Sm. Devine et al., PHASE-I TRIAL OF BUSULFAN (BU), CYCLOPHOSPHAMIDE (CY), AND DIAZIQUONE(AZQ) FOLLOWING AUTOLOGOUS (AU) OR ALLOGENEIC (AL) BONE-MARROW TRANSPLANTATION (BMT), Blood, 86(10), 1995, pp. 831-831
EVALUATION OF SUPPORTIVE CARE GUIDELINES FOR MONITORING BREAST-CANCERBONE-MARROW TRANSPLANT (BMT) PATIENTS IN THE OUTPATIENT SETTING
Authors: MIYAHARA TT DIX SP DEVINE SM HOLLAND HK CONNAGHAN DG FLEMING WH GELLER RB HEFFNER LT HILLYER CD WALLER EK WINTON EF WINGARD JR
Citation: Tt. Miyahara et al., EVALUATION OF SUPPORTIVE CARE GUIDELINES FOR MONITORING BREAST-CANCERBONE-MARROW TRANSPLANT (BMT) PATIENTS IN THE OUTPATIENT SETTING, Blood, 86(10), 1995, pp. 838-838
Risultati: 1-25 | 26-48